Press releases
Access archived Guidant press releases
Access archived BTG press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 23, 2004
and New York, NY (February 23, 2004) -- Boston Scientific Corporation (NYSE: BSX) today hosted a meeting with analysts and investors in New York and addressed growth prospects for the Company in...
-
Feb 20, 2004
(February 20, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has entered into an agreement with Guidant Corporation to settle all outstanding litigation between the two...
-
Feb 20, 2004
(February 20, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has made an equity investment in -- and secured an exclusive option to purchase -- Cameron Health, Inc., a...
-
Feb 19, 2004
(February 19, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received a license for the sale of its Carotid Wallstent® Monorail® Endoprosthesis in Canada. The...
-
Feb 18, 2004
(February 18, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has made an equity investment in and secured an exclusive option to acquire Endoscopic Technologies Inc....
-
Feb 17, 2004
(February 17, 2004) -- Boston Scientific Corporation (NYSE: BSX) will simultaneously webcast an analyst meeting it is hosting on Monday, February 23. The meeting is scheduled to begin at 8:30 a.m....
-
Feb 17, 2004
and Maple Grove, MN (February 17, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced major plant and employment expansion plans in Minnesota, headquarters of its Cardiovascular...
-
Feb 9, 2004
(February 9, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has completed its purchase of the Addition Hill Corporate Center in Marlborough, Massachusetts. The site...
-
Feb 6, 2004
(February 6, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that an inspection team from the U.S. Food and Drug Administration (FDA) has completed its inspection of the...
-
Feb 4, 2004
(February 4, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the start of enrollment in the ARRIVE registry program, which plans to enroll 2,000 patients at approximately 50...